Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response (2014)
- Authors:
- USP affiliated authors: FAJARDO, CRISTINA MORENO - FCF ; HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; RODRIGUES, ALICE CRISTINA - ICB
- Unidades: FCF; ICB
- DOI: 10.4172/2153-0645.1000134
- Subjects: POLIMORFISMO; FARMACOCINÉTICA; TRANSPLANTE DE RIM
- Language: Inglês
- Imprenta:
- Publisher place: Los Angeles
- Date published: 2014
- Source:
- Título: Journal Pharmacogenomics Pharmacoproteomics
- ISSN: 2153-0645
- Volume/Número/Paginação/Ano: v. 5, n. 3, p. 1-16 art. 1000134, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
ALVES, Camila et al. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response. Journal Pharmacogenomics Pharmacoproteomics, v. 5, n. 3, p. 1-16 art. 1000134, 2014Tradução . . Disponível em: https://doi.org/10.4172/2153-0645.1000134. Acesso em: 29 dez. 2025. -
APA
Alves, C., Felipe, C. R., Nishikawa, A. M., Salgado, P. de C., Fajardo, C. M., Silva Junior, H. T., et al. (2014). Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response. Journal Pharmacogenomics Pharmacoproteomics, 5( 3), 1-16 art. 1000134. doi:10.4172/2153-0645.1000134 -
NLM
Alves C, Felipe CR, Nishikawa AM, Salgado P de C, Fajardo CM, Silva Junior HT, Pestana JOM, Zetchaku D, Spinelli G, Oliveira N, Hirata MH, Hirata RDC, Rodrigues AC. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2014 ; 5( 3): 1-16 art. 1000134.[citado 2025 dez. 29 ] Available from: https://doi.org/10.4172/2153-0645.1000134 -
Vancouver
Alves C, Felipe CR, Nishikawa AM, Salgado P de C, Fajardo CM, Silva Junior HT, Pestana JOM, Zetchaku D, Spinelli G, Oliveira N, Hirata MH, Hirata RDC, Rodrigues AC. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2014 ; 5( 3): 1-16 art. 1000134.[citado 2025 dez. 29 ] Available from: https://doi.org/10.4172/2153-0645.1000134 - Association of PPP3CA, FKBP5 and FKBP1B MRNA expression in leucocytes with tacrolimus blood levels in kidney transplant recipients
- Polimorfismos en genes MTOR y PP3CA y su relación con la respuesta a tacrolimus y everolimus en receptores de trasplante renal
- Comparação da eficácia de três métodos de descontaminação de DNA genômico e plasmidal em laboratório de biologia molecular
- Plasmid-based controls to detect rpoB mutations in Mycobacterium tuberculosis by quantitative polymerase chain reaction-high-resolution melting
- Influence CYP2C9, CYP2C19 and VKROC1 gene polymorphisms on warfarin therapeutic requirements in Brazilian individuals
- Association study of E-selectin, MMP9, light, Ltα, VCAM 1, ICAM1 LGALS2 and NF kB gene polymorphism with mRNA expression and serum protein soluble with acute coronary syndrome
- Acute coronary syndrome and gene polymorphisms influence leukocyte MRNA expression of adhesion molecules and inflammatory proteins
- Association of LIGHT polymorphism with response to warfarin therapy in bbrazilian individuals
- Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: role of nitric oxide mediating pleiotropic effects
- Diagnóstico molecular da cardiomiopatia hipertrófica por ultrassequenciamento do exoma de genes específicos
Informações sobre o DOI: 10.4172/2153-0645.1000134 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
